Multimodality imaging and preclinical evaluation of 177Lu-AMBA for human prostate tumours in a murine model.
Liu
I-Hsiang
IH
Institute of Nuclear Energy Research, Taoyuan, Taiwan, ROC.
Chang
Chih-Hsien
CH
Ho
Chung-Li
CL
Chiu
Shu-Pei
SP
Lee
Wan-Chi
WC
Chang
Tsui-Jung
TJ
Chen
Liang-Cheng
LC
Wu
Yu-Hsien
YH
Chuang
Cheng-Hui
CH
Fu
Ying-Kai
YK
Lee
Te-Wei
TW
D000818:Animals; D045744:Cell Line, Tumor; D006801:Humans; D007553:Isotope Labeling; D008163:Luminescent Measurements / Q000379:methods; D008187:Lutetium; D008297:Male; D051379:Mice; D016513:Mice, SCID; D009842:Oligopeptides / Q000097:blood / Q000493:pharmacokinetics*; D011471:Prostatic Neoplasms / Q000097:blood / Q000000981:diagnostic imaging* / Q000378:metabolism*; D011868:Radioisotopes; D019275:Radiopharmaceuticals / Q000097:blood / Q000493:pharmacokinetics*; D014018:Tissue Distribution; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods; D014183:Transplantation, Heterologous
C512446:DO3A-CH2CO-G-4-aminobenzoyl-Q-W-A-V-G-H-L-M-NH2; D009842:Oligopeptides; D011868:Radioisotopes; D019275:Radiopharmaceuticals; D008187:Lutetium